Clinical Trials Logo

Chondrosarcoma, Grade 2 clinical trials

View clinical trials related to Chondrosarcoma, Grade 2.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04278781 Recruiting - Chondrosarcoma Clinical Trials

AG-120 in People With IDH1 Mutant Chondrosarcoma

Start date: March 4, 2020
Phase: Phase 2
Study type: Interventional

This study is being done to see whether AG-120 is an effective and safe treatment for people with advanced/metastatic or recurrent chondrosarcoma that has IDH1 mutation.